Search

Issue
Title
Authors
The effect of extended release metformin on MRI parameters of left ventricular remodeling in patients with prediabetes and heart failure with preserved ejection fraction
Tsygankova O.V., Apartseva N.E., Latyntseva L.D., Nikitin N.A.
Cardiomyopathy associated with the use of anabolic androgenic steroids. Case report
Charaya K.V., Erdniev T.N., Makarenko G.D., Chashkina M.I., Gogiberidze N.A., Dumikyan A.S., Shchekochikhin D.Y., Chomakhidze P.S., Poltavskaya M.G., Andreev D.A.
SGLT-2 inhibitors in the management of acute decompensated heart failure
Poskakalova A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
LOX-1 as a biological marker and therapeutic target in cardiovascular pathology (literature review)
Alieva A.M., Baykova I.E., Reznik E.V., Teplova N.V., Valiev R.K., Gyzyeva M.K., Sultangalieva A.B., Kotikova I.A., Novikova N.A., Korvyakov S.A., Nikitin I.G.
Ischemic heart disease and heart rate monitoring
Kirichenko A.A.
Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region)
Airapetian A.A., Lazareva N.V., Reitblat O.M., Mezhonov E.M., Evgeny E.V., Prints Y.S., Zhirov I.V., Tereshchenko S.N., Boytsov S.A.
Allopurinol in the complex therapy of acute decompensation of heart failure
Sarieva L.H., Muksinova M.D., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Effectiveness and safety of bronchodilator use in chronic cardiac insufficiency of ischemic genesis comorbid with chronic obstructive pulmonary disease
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Voronina G.V.
POSSIBILITIES OF PHARMACEUTICAL TREATMENT OF CARDIOGENIC ENCEPHALOPATHY WITH THE USE OF RUSSIAN MEDICATION WITH METABOLIC ACTION LEVOCARNITINE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CONGESTIVE HEART FAILURE
Mozheiko M.E., Bushueva E.V., Potanina M.V., Ryabikhin E.A.
WHICH ASPECTS ARE THE MOST SIGNIFICANT IN RUSSIAN AND EUROPEAN GUIDELINES? INTERVIEW
Fatal cardio-vascular events risk stratification in ischemic heart disease patients with implantable cardioverter-defibrillators: role of noninvasive electrophysiological predictors
Melnik N.V., Tsaregorodtsev D.A., Ilych I.L., Khamnagadaev I.A., Sulimov V.A.
Trimetazidine (review of the latest foreign publications)
Akatova E.V.
The current status of transcatheter heart valve replacement, using the valve-in-valve technique
Imaev T.E., Komlev A.E., Kolegaev A.S., Lepilin P.M., Akchurin R.S.
The role of percutaneous coronary intervention in the treatment of patients with multivessel coronary artery disease who are turned down for coronary artery bypass grafting (literature review)
Zaynobidinov S.S., Khelimskii D.A., Baranov A.A., Badoian A.G., Tsydenova A.Y., Naydenov R.A., Krestyaninov O.V.
Predictors of class IC antiarrhythmic drugs efficacy in patients with paroxysmal form of atrial fibrillation
Khalikova M.A., Tsaregorodtsev D.A., Beraya M.M., Sedov A.V.
Efficacy and safety of long-term use of prolonged bronchodilators in patients with cardiopulmonary pathology and chronic heart failure
Evdokimov V.V., Yushchuk E.N., Evdokimova A.G., Stryuk R.I.
Captopril effectiveness in treatment of patients with congestive heart failure and cardiopulmonary pathology
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Tereshchenko O.I.
Inhibitor If-sinus channels ivabradine - a drug, increases the effectiveness of treatment of chronic heart failure and coronary heart disease
Trukhan D.I.
Cardiovascular diseases in the long-term after surviving malignant neoplasms: A review
Poltavskaya M.G., Novikova A.I., Bezlyudskiy A.L.
Differential diagnosis of amiodarone-induced thyrotoxicosis in a patient with atrial fibrillation and agranulocytosis on the background of thyrostatic therapy. Case report
Zherebchikova K.Y., Bubnov D.S., Ermolaeva A.S., Soltakhanova M.O., Sych Y.P., Ezhov M.V., Fadeev V.V.
Asthma and cardiovascular disease
Ostroumova O.D., Goloborodova I.V., Voevodina N.Y., Fomina V.M., Seregin A.A.
Myocardial cytoprotection in the treatment of patients with coronary artery disease: Complex clinical cases
Darenskiy D.I.
Possibilities of hyperuricemia correction in acute decompensation of heart failure
Sarieva L.H., Nasonova S.N., Muksinova M.D., Zhirov I.V., Tereshchenko S.N.
Exogenous ketone therapy for heart failure: A review
Aksenova Y.O., Osmolovskaya Y.F., Zhirov I.V., Beniashvili A.G., Morozova M.A., Tereshchenko S.N.
The effect of active diuretic therapy on the sodium balance in patients with acute decompensation of chronic heart failure
Davydov V.V., Arehina E.L.
Chronic heart failure in the practice of the therapist: is it difficult to recognize it?
Kirichenko A.A., Ebseeva E.Y.
Dinical value of blood biomarker ST2 in patients with chronic heart failure
Alieva A.M., Pinchuk T.V., Almazova I.I., Ettinger O.A., Valiev R.K., Batov M.A., Nikitin I.G.
Heart failure and contrast-induced acute kidney injury in patients with coronary artery disease
Mironova O.I., Sivakova O.A., Deev A.D., Fomin V.V.
Management of patients with chronic heart failure and diabetes mellitus from the standpoint of modern recommendations and in real clinical practice
Reznik E.V., Lazarev V.A., Kalova M.R., Nikitin I.G.
PREVENTION AND OVERCOMING OF CARDIOTOXIC EFFECT OF CANCER THERAPY. INTERVIEW
Amyloid heart disease: pathomorphology, diagnostic approaches and treatment options
Rameeva A.S., Rameev V.V., Moiseev S.V., Tao P.P., Kozlovskaya L.V.
Chronic obstructive pulmonary disease and comorbid cardiovascular disease: in the context of guidelines
Ostroumova O.D., Kochetkov A.I.
The role of antagonists of mineralocorticoid receptors in the pharmacotherapy of chronic heart failure
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Dronova Y.M.
Ivabradine in clinical practice
Syrov A.V.
Autonomic heart neuropathy and its correction in type 2 diabetic patients
Krutikov E.S., Tsvetkov V.A., Chistyakova S.I.
Non-compact myocardium of the left ventricle: secondary prevention of thromboembolic complications
Myasnikov R.P., Kulikova O.V., Kharlap M.S., Koretskiy S.N., Andreenko E.Y., Mershina E.A., Sinitsyn V.E., Boytsov S.A.
The relationship between metabolic disorders and insulin resistance in patients with diabetes mellitus
Dorofeeva G.B., Dorofeev I.V.
Vaccine prophylaxis in patients with chronic obstructive pulmonary disease: results of a two-year observation
Ignatova G.L., Antonov V.N., Rodionova O.V.
Molecular mechanisms of inflammation in the development of heart failure: A review
Buziashvili Y.I., Asymbekova E.U., Tugeeva E.F., Rakhimov A.Z., Shakhnazaryan L.S., Akildzhonov F.R.
Endocan is a key player in cardiovascular disease: A review
Alieva A.M., Reznik E.V., Baykova I.E., Teplova N.V., Makeeva L.M., Voronkova K.V., Khadzhieva N.K., Modestova A.V., Totolyan G.G., Valiev R.K., Li A.M., Kotikova I.A., Nikitin I.G.
Pentraxin-3 – a promising biological marker in heart failure: literature review
Alieva A.M., Teplova N.V., Batov M.A., Voronkova K.V., Valiev R.K., Shnakhova L.M., Pinchuk T.V., Rakhaev A.M., Kalova M.R., Nikitin I.G.
Tactics of management of patients with cardiovascular diseases. Roundtable report
Konradi A.O., Baranova E.I., Gurevich V.S., Zvartau N.E., Konstantinov V.O., Nifontov E.M., Obrezan A.G., Panov A.V., Sitnikova M.Y.
AUTONOMIC DYSREFLEXIA IN TETRAPLEGIA AFTER SPINAL CORD INJURY: ORIGINAL ARTICLE
Bushkov F.A., Salyukov R.V.
Algorithm for antihypertensive therapy choice: focus on candesartan
Shekhyan G.G., Yalymov A.A., Shchikota A.M., Timofeeva N.Y., Zadionchenko V.S., Terpigorev S.A., Nikishenkov A.M., Kabanova T.G.
Treatment of chronic heart failure and arterial hypertension: two aims and one drug - fosinopril
Trukhan D.I.
Treatment of chronic heart failure and arterial hypertension: two aims and one drug - torasemide
Trukhan D.I.
Modern possibilities of torasemide application in clinical practice
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Evstigneeva A.S.
Angiotensin II receptor antagonist - candesartan in the arsenal of therapist
Kirichenko A.A.
Glycemic control as a part of coronary stenosis prevention strategy in type 2 diabetes patients before and after transcutaneous coronary intervention
Salukhov V.V., Kadin S.V., Agliullin A.F.
Key features of candesartan application in clinical practice
Evdokimova A.G., Lozhkina M.V., Kovalenko E.V.
Aggravation of coronary heart disease: the balance of risk and the risk of disease treatment
Braznik V.A., Zateyshchikov D.A.
Dynamics of uric acid concentration against the background of early dapagliflozin use in patients with acute decompensation of heart failure
Sarieva L.H., Poskakalova A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Sodium-glucose cotransporter 2 inhibitors: mechanisms of cardiorenal protection: A review
Leonova M.V.
Tumor necrosis factor gene polymorphism rs1800629 in patients with atherosclerotic cardiovascular diseases: A review
Khazova E.V., Bulashova O.V., Valeeva E.V.
Study of the rs1800795 polymorphism of the IL6 gene to verify the clinical portrait of a patient with chronic heart failure: gender aspects
Khazovа E.V., Boulashova O.V., Valeeva E.V.
Rational drug therapy of chronic heart failure: the role of mineralocorticoid receptor antagonists: review
Safronova N.V., Zhirov I.V., Tereshchenko S.N.
The relevance of prescribing triple neurohormonal blockade in real clinical practice: the role of mineralocorticoid receptor antagonists
Zhirov I.V.
P2-ADRENERGIC RECEPTORS GENETIC POLYMORPHISM, CARDIOVASCULAR DISORDERS AND INFLUENCE OF P-BLOCKERS’ EFFECTIVENESS
Leonova M.V.
MILDRONATE USE IN COMPLEX TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ITS INFLUENCE ON HEART AND VESSELS MORPHOFUNCTIONAL STATE
Mikhin V.P., Khlebodarov F.E., Vasil'eva D.A., Gromnatskii N.I.
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: A CHOICE OF THE DRUG IN CLINICAL PRACTICE GIVEN THE EFFECTIVENESS AND SAFETY OF USE
Mubarakshina O.A., Liubavskaia S.S., Somova M.N., Batishcheva G.A.
Percutaneous coronary interventions in comparison with medical therapy in patients with chronic ischemic heart disease: results of long-term follow-up
Kuznetsov V.A., Samoilova E.P., Bessonov I.S., Gultyaeva E.P., Berdinskikh S.G., Gorbatenko E.A., Dyachkov S.M., Yaroslavskaya E.I.
Decreased cardiac mortality with nicorandil in patients with ischemic heart failure
Yoshihisa A., Sato Y., Watanabe S., Yokokawa T., Sato T., Suzuki S., Oikawa M., Kobayashi A., Takeishi Y.
The mineralocorticoid receptor blockers in the treatment of chronic heart failure
Kirichenko A.A.
Clinical aspects of application of candesartan
Rybachkova Y.V.
Liver damage in patients with ischemic chronic heart and type 2 diabetes - a treacherous tandem: possible additional organoprotective therapy
Statsenko M.E., Turkina S.V., Shilina N.N.
The characteristics of torasemide application in patients with arterial hypertension and chronic heart failure
Evdokimov V.V., Evdokimova A.G., Lozhkina M.V., Tebloev K.I.
Efficacy and safety in clinical practice fosinopril
Stryuk R.I.
Real-world effectiveness of remote monitoring of the international normalized ratio in patients undergoing heart valve replacement using the CoaguChek® INRange system with a remote data transmission module
Provatorov S.I., Osokina A.K., Shchinova A.M., Barabanova T.I., Shestova I.I., Mel'nikova E.N.
Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review
Alieva A.M., Teplova N.V., Reznik E.V., Baykova I.E., Khadzhieva N.K., Voronkova K.V., Kovtiukh I.V., Valiev R.K., Kotikova I.A., Nikitin I.G.
The role of interleukin-27 in atherosclerotic cardiovascular diseases: A review
Alieva A.M., Teplova N.V., Reznik E.V., Sarakaeva L.R., Rahaev A.M., Elmurzaeva D.A., Akkiev M.I., Shavaeva M.Y., Akkieva M.A., Nikitin I.G.
Heart failure as a complication of myocardial infarction: rational therapy. Case report
Zhirov I.V., Safronova N.V., Tereshchenko S.N.
Chronic heart failure – modification of treatment paradigm
Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Age aspects of acute myocardial infarction
Khorolets E.V., Shlyk S.V., Bychkova O.I.
Cardiology 2020. The patient with chronic heart failure: a new trajectory of life
Insulin resistance: focus on the pathogenesis of cardiomyopathy
Shishkova V.N., Martynov A.I.
COMPARATIVE PHARMACOEPIDEMIOLOGICAL CHARACTERISTICS OF THE PRESCRIPTIONS OF MEDICINES APPLIED AT PATIENTS WITH CHRONIC HEART FAILURE IN THE CONDITIONS OF TYPICAL PRACTICE OF KURSK AND CHISINAU
Povetkin S.V., Ghicavii V.I., Klyueva E.G., Batchinschi N.G., Pjdgurschi L.A., Turcan L.M.
Cognitive disorders in medical rehabilitation
Krasnov V.S., Shmonin A.A., Maltseva M.N., Melnikova E.V., Ivanova G.E.
Effect of nicorandil on the quality of life and course of the disease in patients with heart failure in ischemic heart disease
Makarovskaya V.V., Ryazanov A.S., Kudryavtsev A.A., Kapitonov K.I.
Modern instrumental diagnosis of coronary heart disease in women and its prognostic importance
Lupanov V.P.
Modern approaches to the use of torasemide in cardiovascular diseases
Baryshnikova G.A., Chorbinskaya S.A., Stepanova I.I.
Pathogenetic substantiation inclusion of taurine in the treatment of patients with diabetes mellitus type 2
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Gorbacheva E.E.
The arsenal of therapist: torasemide
Kirichenko A.A.
Chronic ischemic heart disease: treatment news
Karpov Y.A.
Violations of respiratory function in the combined chronic obstructive pulmonary disease and coronary heart disease
Ignatova G.L., Antonov V.N., Rodionova O.V.
Comparative assessment of arterial stiffness and endothelial dysfunction during treatment with fixed combinations of antihypertensive drugs in patients with arterial hypertension and coronary artery disease
Khakuasheva I.А., Umetov M.A., Urusbieva J.M., Abukova A.K., Didanova L.A.
Hyperuricemia and acute decompensation of heart failure: is there a causative link? A review
Sarieva L.H., Nasonova S.N., Zhirov I.V., Zhirova I.A., Tereshchenko S.N.
Catestanin – a promising biological marker for heart failure: A review
Alieva A.M., Teplova N.V., Reznik E.V., Ettinger O.A., Faradzhov R.A., Khachirova E.A., Kovtiukh I.V., Kotikova I.A., Sysoeva D.A., Bigushev I.R., Nikitin I.G.
Acute decompensated heart failure. What has changed in the clinical guidelines in 2021?
Zhirov I.V., Nasonova S.N., Khalilova U.A., Osmolovskaya Y.F., Zhirova I.A., Gimadiev R.R., Chaikovskaia O.I., Reitblat O.M., Prints I.S., Kochetov A.G., Tereshchenko S.N.
Reducing the risk of chronic heart failure development in patients with arterial hypertension from the position of evidence medicine (focus on candesartan)
Evdokimova A.G., Stryuk R.I., Evdokimov V.V., Golikova A.A.
Pharmacoeconomic analysis of the use of dapagliflozin in patients with NYHA class II-IV chronic heart failure with reduced left ventricular ejection fraction <40% in the Russian Federation
Nedogoda S.V., Tereshhenko S.N., Zhirov I.V., Salasyuk A.S., Villevalde S.V., Barykina I.N., Lutova V.O., Popova E.A.
OPTIMIZATION OF PHARMACOTHERAPY IN A POLYMORBID PATIENT WITH A COMBINATION OF CHRONIC HEART FAILURE AND CHRONIC KIDNEY DISEASE. CLINICAL CASE
Ostroumova O.D., Aliautdinova I.A., Butorov V.N., Kochetkov A.I.
Modern opportunities of nitropreparations in patients with ischemic heart disease: from angina to polymorbidity
Gorokhovskaya G.N., Vasyuk Y.A., Martynov A.I., Maychuk E.Y., Yun V.L., Truten I.V., Petina M.M.
Captopril in cardiovascular disease management
Terpigorev S.A., Nikishenkov A.M., Kabanova T.G., Zadionchenko V.S., Yalymov A.A., Shekhyan G.G., Shchikota A.M., Ivanova N.A., Bogatyrova K.M.
The evolution of mineralocorticoid receptor antagonists: spironolactone and eplerenone
Leonova M.V., Alimova E.E., Eremina Y.N.
Possibilities of perindopril and ivabradin in patients with hypertensive disease in the normalization of hemodynamics, myocardial dysfunction and vascular endothelium
Ivanova O.F., Lebedev P.A., Vvedenskaya I.P., Komarova M.V., Paranina E.V.
Stress-overcoming behaviour in patients with minor heart anomalies: is there an influence of sex?
Kodochigova A.I., Olenko E.S., Kirichuk V.F., Kurako M.M.
The use of proton pump inhibitors in patients with gastroesophageal reflux disease to ischemic heart disease
Komissarenko I.A., Levchenko S.V., Mikheeva O.M.
The course of chronic heart failure, depending on patients’ body composition
Shevtsova V.I., Pashkova A.A., Petrenko A.R., Shevtsov A.N.
Possibilities of noninvasive diagnostics of cardiovascular diseases associated with atherosclerosis
Salyamova L.I., Pavlenko K.I., Khromova A.A., Oleynikov V.E.
Safety of dapagliflozin initiation in acute decompensated heart failure patients with reduced left ventricular ejection fraction
Poskakalova A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
1 - 100 of 145 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».